{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T19:21:56Z","timestamp":1793992916087,"version":"4.8.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,12,13]],"date-time":"2024-12-13T00:00:00Z","timestamp":1734048000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,12,13]],"date-time":"2024-12-13T00:00:00Z","timestamp":1734048000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Gene Ther"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1038\/s41417-024-00869-2","type":"journal-article","created":{"date-parts":[[2024,12,13]],"date-time":"2024-12-13T07:18:59Z","timestamp":1734074339000},"page":"136-145","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["The deubiquitinating enzyme ATXN3 promotes hepatocellular carcinoma progression by stabilizing TAZ"],"prefix":"10.1038","volume":"32","author":[{"given":"Yuanhao","family":"Peng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Nie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuo","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuanxuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2354-5321","authenticated-orcid":false,"given":"Yongguang","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2181-0841","authenticated-orcid":false,"given":"Yangying","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,13]]},"reference":[{"key":"869_CR1","doi-asserted-by":"publisher","first-page":"e000797","DOI":"10.1136\/esmoopen-2020-000797","volume":"5","author":"AX Zhu","year":"2020","unstructured":"Zhu AX, Nipp RD, Finn RS, Galle PR, Llovet JM, Blanc JF, et al. Ramucirumab in the second-line for patients with hepatocellular carcinoma and elevated alpha-fetoprotein: patient-reported outcomes across two randomised clinical trials. ESMO Open. 2020;5:e000797.","journal-title":"ESMO Open"},{"key":"869_CR2","doi-asserted-by":"publisher","first-page":"e000317","DOI":"10.1136\/jitc-2019-000317","volume":"8","author":"Y Yang","year":"2020","unstructured":"Yang Y, Sun M, Yao W, Wang F, Li X, Wang W, et al. Compound kushen injection relieves tumor-associated macrophage-mediated immunosuppression through TNFR1 and sensitizes hepatocellular carcinoma to sorafenib. J Immunother Cancer. 2020;8:e000317.","journal-title":"J Immunother Cancer"},{"key":"869_CR3","doi-asserted-by":"publisher","first-page":"3237","DOI":"10.7150\/thno.69826","volume":"12","author":"N Ding","year":"2022","unstructured":"Ding N, Wang K, Jiang H, Yang M, Zhang L, Fan X, et al. AGK regulates the progression to NASH by affecting mitochondria complex I function. Theranostics. 2022;12:3237\u201350.","journal-title":"Theranostics"},{"key":"869_CR4","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1159\/000487311","volume":"7","author":"Y Sorin","year":"2018","unstructured":"Sorin Y, Ikeda K, Kawamura Y, Fujiyama S, Kobayashi M, Hosaka T, et al. Effectiveness of particle radiotherapy in various stages of hepatocellular carcinoma: a pilot study. Liver cancer. 2018;7:323\u201334.","journal-title":"Liver cancer"},{"key":"869_CR5","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-021-01095-w","volume":"19","author":"Z Li","year":"2021","unstructured":"Li Z, Yang G, Han L, Wang R, Gong C, Yuan Y. Sorafenib and triptolide loaded cancer cell-platelet hybrid membrane-camouflaged liquid crystalline lipid nanoparticles for the treatment of hepatocellular carcinoma. J nanobiotechnology. 2021;19:360.","journal-title":"J nanobiotechnology"},{"key":"869_CR6","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.7150\/thno.29101","volume":"9","author":"Y Gao","year":"2019","unstructured":"Gao Y, Zheng QC, Xu S, Yuan Y, Cheng X, Jiang S, et al. Theranostic nanodots with aggregation-induced emission characteristic for targeted and image-guided photodynamic therapy of hepatocellular carcinoma. Theranostics. 2019;9:1264\u201379.","journal-title":"Theranostics"},{"key":"869_CR7","doi-asserted-by":"publisher","first-page":"128","DOI":"10.3350\/cmh.2016.0071","volume":"23","author":"H Yang","year":"2017","unstructured":"Yang H, Woo HY, Lee SK, Han JW, Jang B, Nam HC, et al. A comparative study of sorafenib and metronomic chemotherapy for Barcelona Clinic Liver Cancer-stage C hepatocellular carcinoma with poor liver function. Clin Mol Hepatol. 2017;23:128\u201337.","journal-title":"Clin Mol Hepatol"},{"key":"869_CR8","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1161\/CIRCRESAHA.118.314048","volume":"124","author":"S Ikeda","year":"2019","unstructured":"Ikeda S, Mizushima W, Sciarretta S, Abdellatif M, Zhai P, Mukai R, et al. Hippo deficiency leads to cardiac dysfunction accompanied by cardiomyocyte dedifferentiation during pressure overload. Circulation Res. 2019;124:292\u2013305.","journal-title":"Circulation Res"},{"key":"869_CR9","doi-asserted-by":"publisher","first-page":"102795","DOI":"10.1016\/j.ebiom.2020.102795","volume":"56","author":"L Wang","year":"2020","unstructured":"Wang L, Lin M, Chu M, Liu Y, Ma J, He Y, et al. SPOP promotes ubiquitination and degradation of LATS1 to enhance kidney cancer progression. EBioMedicine. 2020;56:102795.","journal-title":"EBioMedicine"},{"key":"869_CR10","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.devcel.2018.03.019","volume":"45","author":"Y Xiao","year":"2018","unstructured":"Xiao Y, Hill MC, Zhang M, Martin TJ, Morikawa Y, Wang S, et al. Hippo signaling plays an essential role in cell state transitions during cardiac fibroblast development. Developmental cell. 2018;45:153\u2013169.e156.","journal-title":"Developmental cell"},{"key":"869_CR11","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.ebiom.2018.08.010","volume":"35","author":"M Chen","year":"2018","unstructured":"Chen M, Wu L, Tu J, Zhao Z, Fan X, Mao J, et al. miR-590-5p suppresses hepatocellular carcinoma chemoresistance by targeting YAP1 expression. EBioMedicine. 2018;35:142\u201354.","journal-title":"EBioMedicine"},{"key":"869_CR12","doi-asserted-by":"publisher","DOI":"10.1186\/s13008-016-0013-6","volume":"11","author":"M He","year":"2016","unstructured":"He M, Zhou Z, Shah AA, Hong Y, Chen Q, Wan Y. New insights into posttranslational modifications of Hippo pathway in carcinogenesis and therapeutics. Cell Div. 2016;11:4.","journal-title":"Cell Div"},{"key":"869_CR13","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/ncb3073","volume":"17","author":"B Ma","year":"2015","unstructured":"Ma B, Chen Y, Chen L, Cheng H, Mu C, Li J, et al. Hypoxia regulates Hippo signalling through the SIAH2 ubiquitin E3 ligase. Nat cell Biol. 2015;17:95\u2013103.","journal-title":"Nat cell Biol"},{"key":"869_CR14","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1038\/ncb3028","volume":"16","author":"R Nishi","year":"2014","unstructured":"Nishi R, Wijnhoven P, le Sage C, Tjeertes J, Galanty Y, Forment JV, et al. Systematic characterization of deubiquitylating enzymes for roles in maintaining genome integrity. Nat cell Biol. 2014;16:1016\u201326. 1011-1018","journal-title":"Nat cell Biol"},{"key":"869_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-10739-3","volume":"10","author":"R Zhu","year":"2019","unstructured":"Zhu R, Gires O, Zhu L, Liu J, Li J, Yang H, et al. TSPAN8 promotes cancer cell stemness via activation of sonic Hedgehog signaling. Nat Commun. 2019;10:2863.","journal-title":"Nat Commun"},{"key":"869_CR16","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.canlet.2019.09.012","volume":"467","author":"H Zou","year":"2019","unstructured":"Zou H, Chen H, Zhou Z, Wan Y, Liu Z. ATXN3 promotes breast cancer metastasis by deubiquitinating KLF4. Cancer Lett. 2019;467:19\u201328.","journal-title":"Cancer Lett"},{"key":"869_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-022-04781-1","volume":"13","author":"J Tang","year":"2022","unstructured":"Tang J, Luo Y, Xiao L. USP26 promotes anaplastic thyroid cancer progression by stabilizing TAZ. Cell Death Dis. 2022;13:326.","journal-title":"Cell Death Dis"},{"key":"869_CR18","doi-asserted-by":"publisher","first-page":"821","DOI":"10.7150\/jca.82066","volume":"14","author":"Y Peng","year":"2023","unstructured":"Peng Y, Ouyang L, Zhou Y, Lai W, Chen Y, Wang Z, et al. AhR Promotes the Development of Non-small cell lung cancer by Inducing SLC7A11-dependent Antioxidant Function. J Cancer. 2023;14:821\u201334.","journal-title":"J Cancer"},{"key":"869_CR19","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1186\/s13045-020-01013-x","volume":"13","author":"Y Zhou","year":"2020","unstructured":"Zhou Y, Lih TM, Pan J, H\u00f6ti N, Dong M, Cao L, et al. Proteomic signatures of 16 major types of human cancer reveal universal and cancer-type-specific proteins for the identification of potential therapeutic targets. J Hematol Oncol. 2020;13:170.","journal-title":"J Hematol Oncol"},{"key":"869_CR20","first-page":"14","volume":"1","author":"G Bertino","year":"2012","unstructured":"Bertino G. Hepatocellular carcinoma: present and future. Chin Clin Oncol. 2012;1:14.","journal-title":"Chin Clin Oncol"},{"key":"869_CR21","doi-asserted-by":"publisher","first-page":"796","DOI":"10.7150\/thno.28992","volume":"9","author":"YL Zheng","year":"2019","unstructured":"Zheng YL, Li L, Jia YX, Zhang BZ, Li JC, Zhu YH, et al. LINC01554-mediated glucose metabolism reprogramming suppresses tumorigenicity in hepatocellular carcinoma via downregulating PKM2 expression and inhibiting Akt\/mTOR signaling pathway. Theranostics. 2019;9:796\u2013810.","journal-title":"Theranostics"},{"key":"869_CR22","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1111\/j.1365-2753.2010.01599.x","volume":"18","author":"M Patel","year":"2012","unstructured":"Patel M, Shariff MI, Ladep NG, Thillainayagam AV, Thomas HC, Khan SA, et al. Hepatocellular carcinoma: diagnostics and screening. J evaluation Clin Pract. 2012;18:335\u201342.","journal-title":"J evaluation Clin Pract"},{"key":"869_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-26448-9","volume":"12","author":"X Liu","year":"2021","unstructured":"Liu X, Yang W, Petrick JL, Liao LM, Wang W, He N, et al. Higher intake of whole grains and dietary fiber are associated with lower risk of liver cancer and chronic liver disease mortality. Nat Commun. 2021;12:6388.","journal-title":"Nat Commun"},{"key":"869_CR24","doi-asserted-by":"publisher","first-page":"5404","DOI":"10.1074\/jbc.TM117.000117","volume":"293","author":"P Grumati","year":"2018","unstructured":"Grumati P, Dikic I. Ubiquitin signaling and autophagy. J Biol Chem. 2018;293:5404\u201313.","journal-title":"J Biol Chem"},{"key":"869_CR25","doi-asserted-by":"publisher","first-page":"130131","DOI":"10.1098\/rsob.130131","volume":"3","author":"DE Nelson","year":"2013","unstructured":"Nelson DE, Randle SJ, Laman H. Beyond ubiquitination: the atypical functions of Fbxo7 and other F-box proteins. Open Biol. 2013;3:130131.","journal-title":"Open Biol"},{"key":"869_CR26","doi-asserted-by":"publisher","first-page":"60","DOI":"10.3390\/biom11010060","volume":"11","author":"G \u00c7etin","year":"2021","unstructured":"\u00c7etin G, Klafack S, Studencka-Turski M, Kr\u00fcger E, Ebstein F. The ubiquitin-proteasome system in immune cells. Biomolecules. 2021;11:60.","journal-title":"Biomolecules"},{"key":"869_CR27","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1016\/j.immuni.2010.12.007","volume":"33","author":"BA Malynn","year":"2010","unstructured":"Malynn BA, Ma A. Ubiquitin makes its mark on immune regulation. Immunity. 2010;33:843\u201352.","journal-title":"Immunity"},{"key":"869_CR28","doi-asserted-by":"publisher","first-page":"9721","DOI":"10.1093\/nar\/gkz726","volume":"47","author":"X Ting","year":"2019","unstructured":"Ting X, Xia L, Yang J, He L, Si W, Shang Y, et al. USP11 acts as a histone deubiquitinase functioning in chromatin reorganization during DNA repair. Nucleic acids Res. 2019;47:9721\u201340.","journal-title":"Nucleic acids Res"},{"key":"869_CR29","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1080\/15548627.2019.1570063","volume":"15","author":"X Feng","year":"2019","unstructured":"Feng X, Jia Y, Zhang Y, Ma F, Zhu Y, Hong X, et al. Ubiquitination of UVRAG by SMURF1 promotes autophagosome maturation and inhibits hepatocellular carcinoma growth. Autophagy. 2019;15:1130\u201349.","journal-title":"Autophagy"},{"key":"869_CR30","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1038\/s41418-022-01051-7","volume":"30","author":"Q Chen","year":"2023","unstructured":"Chen Q, Zheng W, Guan J, Liu H, Dan Y, Zhu L, et al. SOCS2-enhanced ubiquitination of SLC7A11 promotes ferroptosis and radiosensitization in hepatocellular carcinoma. Cell death Differ. 2023;30:137\u201351.","journal-title":"Cell death Differ"},{"key":"869_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-021-04124-6","volume":"12","author":"M Xie","year":"2021","unstructured":"Xie M, Fu XG, Jiang K. Notch1\/TAZ axis promotes aerobic glycolysis and immune escape in lung cancer. Cell Death Dis. 2021;12:832.","journal-title":"Cell Death Dis"},{"key":"869_CR32","doi-asserted-by":"publisher","DOI":"10.15252\/embj.2022111549","volume":"42","author":"B Yuan","year":"2023","unstructured":"Yuan B, Liu J, Shi A, Cao J, Yu Y, Zhu Y, et al. HERC3 promotes YAP\/TAZ stability and tumorigenesis independently of its ubiquitin ligase activity. EMBO J. 2023;42:e111549.","journal-title":"EMBO J"},{"key":"869_CR33","doi-asserted-by":"publisher","first-page":"2181","DOI":"10.1038\/onc.2010.606","volume":"30","author":"Z Zhou","year":"2011","unstructured":"Zhou Z, Hao Y, Liu N, Raptis L, Tsao MS, Yang X. TAZ is a novel oncogene in non-small cell lung cancer. Oncogene. 2011;30:2181\u20136.","journal-title":"Oncogene"},{"key":"869_CR34","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1111\/jop.12062","volume":"42","author":"Z Wei","year":"2013","unstructured":"Wei Z, Wang Y, Li Z, Yuan C, Zhang W, Wang D, et al. Overexpression of Hippo pathway effector TAZ in tongue squamous cell carcinoma: correlation with clinicopathological features and patients\u2019 prognosis. J Oral Pathol Med: Off Publ Int Assoc Oral Pathologists Am Acad Oral Pathol. 2013;42:747\u201354.","journal-title":"J Oral Pathol Med: Off Publ Int Assoc Oral Pathologists Am Acad Oral Pathol"},{"key":"869_CR35","doi-asserted-by":"publisher","first-page":"e167728","DOI":"10.1172\/JCI167728","volume":"133","author":"S Wang","year":"2023","unstructured":"Wang S, Iyer R, Han X, Wei J, Li N, Cheng Y, et al. CRISPR screening identifies the deubiquitylase ATXN3 as a PD-L1-positive regulator for tumor immune evasion. J Clin Investig. 2023;133:e167728.","journal-title":"J Clin Investig"},{"key":"869_CR36","doi-asserted-by":"publisher","first-page":"e2000733","DOI":"10.1371\/journal.pbio.2000733","volume":"14","author":"H Liu","year":"2016","unstructured":"Liu H, Li X, Ning G, Zhu S, Ma X, Liu X, et al. The Machado-Joseph Disease Deubiquitinase Ataxin-3 Regulates the Stability and Apoptotic Function of p53. PLoS Biol. 2016;14:e2000733.","journal-title":"PLoS Biol"},{"key":"869_CR37","first-page":"973","volume":"7","author":"LX Zeng","year":"2014","unstructured":"Zeng LX, Tang Y, Ma Y. Ataxin-3 expression correlates with the clinicopathologic features of gastric cancer. Int J Clin Exp Med. 2014;7:973\u201381.","journal-title":"Int J Clin Exp Med"}],"container-title":["Cancer Gene Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41417-024-00869-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41417-024-00869-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41417-024-00869-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,27]],"date-time":"2025-01-27T10:56:04Z","timestamp":1737975364000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41417-024-00869-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,13]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["869"],"URL":"https:\/\/doi.org\/10.1038\/s41417-024-00869-2","relation":{},"ISSN":["0929-1903","1476-5500"],"issn-type":[{"value":"0929-1903","type":"print"},{"value":"1476-5500","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,13]]},"assertion":[{"value":"17 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 December 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 December 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 December 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}